Oral glutathione administration inhibits the oxidative stress and the inflammatory responses in AppNL-G-F/NL-G-F knock-in mice.

Neuropharmacology
Hisanao IzumiK Fukunaga

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease characterized by the presence of extracellular amyloid-β (Aβ) plaques and intracellular neurofibrillary tangles. Reduced antioxidants and increased oxidative stress and inflammation are responsible for the pathological features characteristic of an AD brain. We observed decreased levels of the reduced form of glutathione (GSH), the most abundant brain antioxidant, and decreased GSH/glutathione disulfide (GSSG) ratios in AppNL-G-F/NL-G-F knock-in (NL-G-F) mouse brains. Repeated oral GSH administration for 3 weeks dose-dependently increased GSH levels and restored the GSH/GSSH ratio. Consistent with the restoration of GSH levels, the levels of 4-hydroxy-2-nonenal (4-HNE), a marker of oxidative stress, were significantly decreased in the hippocampus of NL-G-F mice. Additionally, inflammatory responses, such as microgliosis and increased mRNA expression of inflammatory cytokines, were also inhibited. Moreover, behavioral deficits including cognitive decline, depressive-like behaviors, and anxiety-related behaviors observed in NL-G-F mice were significantly improved by oral and chronic GSH administration. Taken together, our data suggest that oral GSH administrati...Continue Reading

References

Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C D SmithW R Markesbery
Jun 1, 1990·The Journal of Clinical Investigation·R KannanN Kaplowitz
Oct 1, 1990·The American Journal of Physiology·T M HagenD P Jones
Jan 1, 1983·Annual Review of Biochemistry·A Meister, M E Anderson
Nov 1, 1994·Annals of Neurology·P MecocciM F Beal
May 30, 1994·Biochemical and Biophysical Research Communications·B V ZlokovicR Kannan
May 22, 1998·Journal of Neuropathology and Experimental Neurology·K S MontineT J Montine
Nov 3, 1998·Journal of Neurochemistry·S P GabbitaW R Markesbery
Aug 7, 2001·Journal of Neuropathology and Experimental Neurology·A NunomuraM A Smith
Oct 26, 2002·Science·Dennis J Selkoe
Sep 17, 2004·The Journal of Biological Chemistry·Uta KeilAnne Eckert
Dec 23, 2004·Journal of Neural Transmission·Y TongW Song
Feb 22, 2005·Free Radical Biology & Medicine·Quan LiuGeorge Perry
Jan 10, 2006·Neurobiology of Aging·Ilaria GuidiElio Scarpini
Feb 2, 2006·Neurobiology of Aging·Joseph F QuinnRobert W Stackman
Feb 3, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chong-Bin ZhuWilliam A Hewlett
Oct 13, 2006·Antioxidants & Redox Signaling·Vittorio CalabreseD A Butterfield
Nov 4, 2006·Science·Michel Goedert, Maria Grazia Spillantini
Mar 21, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Chirag KariyaBrian J Day
Jun 21, 2007·PloS One·Simon MelovAshley I Bush
Apr 22, 2008·Free Radical Biology & Medicine·Rosa ResendeCatarina Resende Oliveira
Sep 18, 2008·Molecular Aspects of Medicine·Henry Jay FormanAlessandra Rinna
Jan 20, 2010·Journal of Neuropathology and Experimental Neurology·Mubeen A Ansari, Stephen W Scheff
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
Jan 7, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Norifumi ShiodaKohji Fukunaga
Oct 22, 2011·Biochimica Et Biophysica Acta·Chava B Pocernich, D Allan Butterfield
Jan 11, 2012·Antioxidants & Redox Signaling·Kristina LeunerWalter E Müller
Mar 10, 2012·Life Sciences·Oliver Wirths, Thomas A Bayer
Mar 20, 2012·Cell·Yadong Huang, Lennart Mucke
Jul 21, 2012·Advances in Protein Chemistry and Structural Biology·Samina SalimMohammad Asghar
Sep 22, 2012·Biochimica Et Biophysica Acta·Shelly C Lu
Nov 28, 2012·Molecular Psychiatry·J H LedoS T Ferreira
May 21, 2013·European Journal of Pharmacology·N RajasekarRakesh Shukla
Nov 6, 2013·Biochimica Et Biophysica Acta·Xinglong WangXiongwei Zhu
Feb 6, 2014·Journal of Alzheimer's Disease : JAD·Sumiti Saharan, Pravat K Mandal

❮ Previous
Next ❯

Citations

Apr 17, 2021·Journal of Pharmacological Sciences·Tomohide DegawaKohji Fukunaga
Sep 14, 2021·GeroScience·Nidheesh ThadathilSathyaseelan S Deepa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.